These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23093870)

  • 1. Evaluation of drug promotional materials in a hospital setting in Nepal.
    Alam K; Shah AK; Ojha P; Palaian S; Shankar PR
    South Med Rev; 2009 Apr; 2(1):2-6. PubMed ID: 23093870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
    Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
    J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the reliability and accuracy of the promotional brochures for the generic pharmaceutical companies in Iraq using World Health Organization guidelines.
    Mikhael EM
    J Pharm Bioallied Sci; 2015; 7(1):65-8. PubMed ID: 25709340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribers Perception on Drug Promotional Literatures in A Tertiary Care Hospital in Nepal.
    Prasad P; Mudvari A; Ghimire R; Karki N; Yadav D; Shah S; Gyanwali P
    J Nepal Health Res Counc; 2021 Apr; 19(1):19-25. PubMed ID: 33934127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Appraisal of Drug Promotional Literature in Accordance With WHO Guidelines.
    Rode SB; Salankar HV; Katole NT; Deshkar AT; Dadmal AA; Parate SV
    Cureus; 2022 Aug; 14(8):e27644. PubMed ID: 36072198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What patients think about promotional activities of pharmaceutical companies in Turkey.
    Semin S; Güldal D; Ozçakar N; Mevsim V
    Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of rationality of promotional drug literature using World Health Organization guidelines.
    Mali SN; Dudhgaonkar S; Bachewar NP
    Indian J Pharmacol; 2010 Oct; 42(5):267-72. PubMed ID: 21206615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of perceptions and exposure of drug promotional literature among clinicians in a teaching hospital.
    Sharma S; Akhoon N; Moe HW; Nair DR; Shashidhar V
    Perspect Clin Res; 2021; 12(3):140-145. PubMed ID: 34386378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance of disease awareness campaigns in printed Dutch media with national and international regulatory guidelines.
    Leonardo Alves T; Martins de Freitas AF; van Eijk ME; Mantel-Teeuwisse AK
    PLoS One; 2014; 9(9):e106599. PubMed ID: 25198776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical review of drug promotional literature using the World Health Organization guidelines.
    Ganashree P; Bhuvana K; Sarala N
    J Res Pharm Pract; 2016; 5(3):162-5. PubMed ID: 27512705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.
    Zetterqvist AV; Merlo J; Mulinari S
    PLoS Med; 2015 Feb; 12(2):e1001785. PubMed ID: 25689460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical evaluation of the validity of drug promotion materials in Ethiopia.
    Hailu HG; Gobezie MY; Yesuf TA; Workneh BD
    Drug Healthc Patient Saf; 2019; 11():47-54. PubMed ID: 31440103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India.
    Gupta SK; Nayak RP; Sivaranjani R
    J Pharm Bioallied Sci; 2016; 8(1):47-51. PubMed ID: 26957869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of drug promotional literatures published in scientific medical journals.
    Vachhani PM; Solanki MN; Desai MK
    J Pharm Bioallied Sci; 2016; 8(3):248-52. PubMed ID: 27413355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
    Vilhelmsson A; Davis C; Mulinari S
    PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Review of the Drug Promotional Literature Published in Scientific Medical Journals and Available at Outpatient Departments: A Cross-Sectional Observational Study.
    Vivek K; Deolekar P; Naseem A; Langade DG; Yadav P
    Cureus; 2022 Nov; 14(11):e31283. PubMed ID: 36514598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.